BELVIN MARCIA

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 94% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
BELVIN MARCIA's trades of CytomX Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-19 2026-03-17 S Sale
69,920 +20.4%
460.47
US$2,309,092
69,920 +20.4% 460.47 US$2,309,092
2025-06-17 2025-06-16 S Sale
96,630 +22.5%
365.29
US$2,203,365
96,630 +22.5% 365.29 US$2,203,365
2025-03-20 2025-03-18 S Sale
67,568 -18.2%
122.82
US$4,461,745
67,568 -18.2% 122.82 US$4,461,745
2024-08-22 2024-08-20 S Sale
4,181 -2.3%
1.23
US$5,139
4,181 -2.3% 1.23 US$5,139
2024-03-21 2024-03-19 S Sale
12,795 -7.1%
2.09
US$26,684
12,795 -7.1% 2.09 US$26,684
2023-12-22 2023-12-20 S Sale
4,077 -2.6%
1.38
US$5,628
4,077 -2.6% 1.38 US$5,628
2023-09-22 2023-09-22 S Sale
4,119 -2.7%
1.30
US$5,356
4,119 -2.7% 1.30 US$5,356